Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jun;42(6):3217-3230.
doi: 10.21873/anticanres.15812.

Republication: Targeting PI3KC2β Impairs Proliferation and Survival in Acute Leukemia, Brain Tumours and Neuroendocrine Tumours

Danielle Boller #  1 , Kathrin T Doepfner #  1 , Angela DE Laurentiis  1 , Ana S Guerreiro  1 , Marin Marinov  1 , Tarek Shalaby  2 , Paul Depledge  3 , Anthony Robson  3 , Nahid Saghir  3 , Masahiko Hayakawa  4 , Hiroyuki Kaizawa  4 , Tomonobu Koizumi  4 , Takahide Ohishi  4 , Sarah Fattet  5 , Olivier Delattre  5 , Anelia Schweri-Olac  6 , Katrin Höland  6 , Michael A Grotzer  2 , Karl Frei  7 , Olivier Spertini  8 , Michael D Waterfield  3   9 , Alexandre Arcaro  10   6
Affiliations
Free article

Republication: Targeting PI3KC2β Impairs Proliferation and Survival in Acute Leukemia, Brain Tumours and Neuroendocrine Tumours

Danielle Boller et al. Anticancer Res. 2022 Jun.
Free article

Abstract

Background: Eight human catalytic phosphoinositide 3-kinase (PI3K) isoforms exist which are subdivided into three classes. While class I isoforms have been well-studied in cancer, little is known about the functions of class II PI3Ks.

Materials and methods: The expression pattern and functions of the class II PI3KC2β isoform were investigated in a panel of tumour samples and cell lines.

Results: Overexpression of PI3KC2β was found in subsets of tumours and cell lines from acute myeloid leukemia (AML), glioblastoma multiforme (GBM), medulloblastoma (MB), neuroblastoma (NB), and small cell lung cancer (SCLC). Specific pharmacological inhibitors of PI3KC2β or RNA interference impaired proliferation of a panel of human cancer cell lines and primary cultures. Inhibition of PI3KC2β also induced apoptosis and sensitised the cancer cells to chemotherapeutic agents.

Conclusion: Together, these data show that PI3KC2β contributes to proliferation and survival in AML, brain tumours and neuroendocrine tumours, and may represent a novel target in these malignancies.

Keywords: PI3KC2β; acute leukemia; brain tumours; cell proliferation; migration; neuroendocrine tumours; pharmacological inhibition.

PubMed Disclaimer

MeSH terms